[1]Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China,2019[J]. N Engl J Med, 2020, 382(8):727-733.doi: 10.1056/NEJMoa2001017.
[2]World Health Organization. Statement on the second meeting of the International Health Regulation (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-stateme -nt-on-the-second-meeting-of-the-international-health-regulations-(2005)-emerge-ncy -committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
[3]World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020.https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.
[4]World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. https://ww w.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.
[5] World Health Organization. Coronavirus disease (COVID-2019) situation reports. World Health Organization.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2020 0728-covid-19-sitrep-190.pdf?sfvrsn=fec17314_2.
[6]Bassetti M, Vena A, Giacobbe DR. The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm[J]. Eur J Clin Invest, 2020,50 (3):e13209.doi:10.1111/eci.13209.
[7]Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany[J]. N Engl J Med, 2020, 382(10):970-971.doi:10.1056 / NEJMc2001468.
[8]Wang LS, Wang YR, Ye DW, et al. A review of the 2019 Novel Coronavirus (COVID-1 9) based on current evidence[J].Int J Antimicrob Agents, 2020.doi:1 0.1016/j.ijantimicag.2020.105948.
[9]Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13(5):667-673. doi:10.1016/j.jiph.2020.03.019
[10]Xinhuanet Nan-shan ZHONG’s and Lan-juan LI’s teams isolated the virus from the stools of patients with new coronary pneumonia. Xinhuanet. http://m.xinhuanet. com/hb/2020-02/13/c_1125570909.htm [Accessed on Feb. 28, 2020]; 2020. (in Chinese)
[11]Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020[J]. Euro Surveill, 2020, 25(4). doi:10.2807/1560-7917.
[12]Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21(5):343-360. doi:10.1631/jzus.B2000083
[13]Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia[J]. N Engl J Med, 2020, 382(13):1199-1207. doi:10. 1056/ NEJMoa2001316.
[14]Liu Y, Gayle AA, Wilder-Smith A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus[J]. J Travel Med, 2020, 27(2).doi:1 0.1093/jtm/taaa021.
[15]Tang B, Wang X, Li Q, et al. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions[J]. J Clin Med, 2020,9(2). doi:10.3390/jcm9020462.
[16]World Health Organization. Novel Coronavirus (2019-nCoV) advice for the public: Myth buster.http://www.who.int/emergencies/diseases/novel-coronavirus-2019 /advice-for-public/myth -buster.
[17]Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV[J]. Viruses, 2020,12(2):135. doi:10.3390/v12020135.
[18] Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic?. Lancet. 2020;395(10222):391-393. doi:10.1016/S0140-6736(20)30300-7
[19]General Office of National Health Commission of the People's of Republic of China, General Office of National Administration of Traditional Chinese Medicine. General Office of National Health Commission of the People's of Republic of China. Diagnosis and treatment protocol for COVID-19(trial version 7)[EB/OL].(2020-03-03)[2020-03-11]..
[20]Ye Lixia, Wang Haibin, Lu Huaichu, Chen Bingbing, Zhu Yingying, Gu Shaohua, Wang Jianmei, Pan Xingqiang, Fang Ting, Dong Hongjun. Investigation of a cluster epidemic of COVID-19 in Ningbo[J]. Chinese Journal of Epidemiology, 2020, 41(0): 0-0.
[21]Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020;9(1):24. Published 2020 Feb 28. doi:10.1186/s40249-020-00640-3
[22]Yuan J, Li M, Lv G, Lu ZK. Monitoring transmissibility and mortality of COVID-19 in Europe. Int J Infect Dis. 2020;95:311-315. doi:10.1016/j.ijid.2020.03.050.
[23]Mahase E. China coronavirus: what do we know so far? BMJ (Clinical researched) 2020,368: m308.doi: 10.1136/bmj.m308.
[24]Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-576. doi:10.1002/jmv.25748.
[25]Bulut C, Kato Y. Epidemiology of COVID-19[J]. Turk J Med Sci. 2020;50(SI-1):563-570. doi:10.3906/sag-2004-172.
[26Bai Y, Yao LS, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19[J]. JAMA, 2020.doi:10.1001/jama.2020.2565.
[27]European Centre for Disease Prevention and Control (ECDC).Q & A on novel coronavirus. Stockholm:ECDC;2020.https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers.
[28]Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill, 2020,25(5). doi:10.2807/1560-7917.
[29]Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med, 2020.doi:10.1056/NEJMoa2002032.
[30] Yang HY, Xu J, Li Y, et al. The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease[J]. Chin J Epidemiol, 2020, 41(5): 623-628. doi: 10.3760/cma.j.cn112338-20200223-00153.
[31] Izzetti R, Nisi M, Gabriele M, et al. COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy. J Dent Res. 2020;99(9):1030-1038. doi:10.1177/0022034520920580.
[32] Abdollahi E, Champredon D, Langley JM, Galvani AP, Moghadas SM. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States. CMAJ. 2020;192(25):E666-E670. doi:10.1503/cmaj.200711.